BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Treatment
53 results:

  • 1. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
    Olaleye OO; Kim DH; Spriggs KA
    BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma.
    Bai J; Li X; Wen Y; Lu Q; Chen R; Liu R; Shangguan T; Ye Y; Lin J; Cai W; Kang D; Chen J
    Aging (Albany NY); 2024 Feb; 16(4):3631-3646. PubMed ID: 38376408
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary lymphoma of the uterine cervix: a clinicopathologic study of 13 cases with review of additional 54 cases in the literature.
    Weng X; Huang M; Zhang M; Yang Y; Liu X; Huang Y
    Virchows Arch; 2023 Feb; 482(2):419-429. PubMed ID: 36350409
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
    Xu Y; Kong W; Cao M; Wang J; Wang Z; Zheng L; Wu X; Cheng R; He W; Yang B; Dong B; Pan J; Chen Y; Huang J; Jiang C; Zhai W; Li F; Chen R; Zhou X; Wu G; Geng X; Chen J; An H; Yuan Y; Xu T; Chen D; Lin D; Xu L; Huang K; Peng L; Yu Y; Tai S; Qi H; Luo K; Kang X; Wang H; Huang Y; Zhang J; Xue W
    Eur Urol; 2023 Feb; 83(2):163-172. PubMed ID: 35715365
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cyst(e)inase-Rapamycin Combination Induces Ferroptosis in Both In Vitro and In Vivo Models of Hereditary Leiomyomatosis and Renal Cell cancer.
    Kerimoglu B; Lamb C; McPherson RD; Ergen E; Stone EM; Ooi A
    Mol Cancer Ther; 2022 Mar; 21(3):419-426. PubMed ID: 35086957
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (hlrcc) syndrome can be identified through distinct clinical characteristics and typical morphology.
    Uimari O; Ahtikoski A; Kämpjärvi K; Butzow R; Järvelä IY; Ryynänen M; Aaltonen LA; Vahteristo P; Kuismin O
    Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2066-2075. PubMed ID: 34480341
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
    Chi RA; van der Watt P; Wei W; Birrer MJ; Leaner VD
    BMC Cancer; 2021 Feb; 21(1):106. PubMed ID: 33530952
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review.
    Chayed Z; Kristensen LK; Ousager LB; Rønlund K; Bygum A
    Orphanet J Rare Dis; 2021 Jan; 16(1):34. PubMed ID: 33461594
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical characteristics and treatments of hereditary leiomyomatosis renal cell carcinoma: two case reports and literature review.
    Feng D; Wang M; Zhang X; Wang J
    Aktuelle Urol; 2021 Feb; 52(1):58-63. PubMed ID: 32932527
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fumarate hydratase as a therapeutic target in renal cancer.
    Kancherla P; Daneshvar M; Sager RA; Mollapour M; Bratslavsky G
    Expert Opin Ther Targets; 2020 Sep; 24(9):923-936. PubMed ID: 32744123
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting the B-cell lymphoma 2 anti-apoptotic proteins for cervical cancer treatment.
    Abdul Rahman SF; Xiang Lian BS; Mohana-Kumaran N
    Future Oncol; 2020 Oct; 16(28):2235-2249. PubMed ID: 32715755
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Complete response of hereditary leiomyomatosis and renal cell cancer (hlrcc)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report.
    Iribe Y; Furuya M; Shibata Y; Yasui M; Funahashi M; Ota J; Iwashita H; Nagashima Y; Hasumi H; Hayashi N; Makiyama K; Kondo K; Tanaka R; Yao M; Nakaigawa N
    Fam Cancer; 2021 Jan; 20(1):75-80. PubMed ID: 32666341
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tobramycin suppresses HUWE1 degradation to control mcl-1 stability during tumour development.
    He J; Wu S; Li X; Tang L; Chen H; Qin L; Xie J; Lu T; Xu W
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1600-1610. PubMed ID: 32378766
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses.
    El-Zaatari Z; Divatia MK
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S7-S17. PubMed ID: 32108620
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ferulic Acid Induces Apoptosis of HeLa and Caski Cervical Carcinoma Cells by Down-Regulating the Phosphatidylinositol 3-Kinase (PI3K)/Akt Signaling Pathway.
    Luo L; Zhu S; Tong Y; Peng S
    Med Sci Monit; 2020 Jan; 26():e920095. PubMed ID: 31983729
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes.
    Podkalicka P; Mucha O; Kruczek S; Biela A; Andrysiak K; Stępniewski J; Mikulski M; Gałęzowski M; Sitarz K; Brzózka K; Józkowicz A; Dulak J; Łoboda A
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963199
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. α-Mangostin attenuates stemness and enhances cisplatin-induced cell death in cervical cancer stem-like cells through induction of mitochondrial-mediated apoptosis.
    Chien HJ; Ying TH; Hsieh SC; Lin CL; Yu YL; Kao SH; Hsieh YH
    J Cell Physiol; 2020 Jul; 235(7-8):5590-5601. PubMed ID: 31960449
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. treatment of three hereditary leiomyomatosis patients with cryotherapy.
    Uyar B; Acar EM; Subaşıoğlu A
    Dermatol Ther; 2020 Mar; 33(2):e13226. PubMed ID: 31917494
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Advances in hereditary leiomyomatosis and renal cell carcinoma (hlrcc) research.
    Ooi A
    Semin Cancer Biol; 2020 Apr; 61():158-166. PubMed ID: 31689495
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Familial Kidney cancer: Implications of New Syndromes and Molecular Insights.
    Carlo MI; Hakimi AA; Stewart GD; Bratslavsky G; Brugarolas J; Chen YB; Linehan WM; Maher ER; Merino MJ; Offit K; Reuter VE; Shuch B; Coleman JA
    Eur Urol; 2019 Dec; 76(6):754-764. PubMed ID: 31326218
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.